Logo image of CLX

CLOROX COMPANY (CLX) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:CLX - US1890541097 - Common Stock

100.83 USD
+0.02 (+0.02%)
Last: 12/31/2025, 7:49:24 PM
100.83 USD
0 (0%)
After Hours: 12/31/2025, 7:49:24 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to CLX. CLX was compared to 12 industry peers in the Household Products industry. While CLX is still in line with the averages on profitability rating, there are concerns on its financial health. CLX is valued correctly, but it does not seem to be growing. Finally CLX also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year CLX was profitable.
CLX had a positive operating cash flow in the past year.
CLX had positive earnings in each of the past 5 years.
In the past 5 years CLX always reported a positive cash flow from operatings.
CLX Yearly Net Income VS EBIT VS OCF VS FCFCLX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

1.2 Ratios

The Return On Assets of CLX (14.31%) is better than 83.33% of its industry peers.
CLX's Return On Invested Capital of 21.90% is fine compared to the rest of the industry. CLX outperforms 75.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CLX is above the industry average of 14.85%.
The 3 year average ROIC (18.59%) for CLX is below the current ROIC(21.90%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 14.31%
ROE N/A
ROIC 21.9%
ROA(3y)7.31%
ROA(5y)8.13%
ROE(3y)135.14%
ROE(5y)132.26%
ROIC(3y)18.59%
ROIC(5y)17.73%
CLX Yearly ROA, ROE, ROICCLX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50 100 150 200 250

1.3 Margins

Looking at the Profit Margin, with a value of 11.68%, CLX is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
In the last couple of years the Profit Margin of CLX has declined.
CLX's Operating Margin of 15.17% is in line compared to the rest of the industry. CLX outperforms 50.00% of its industry peers.
CLX's Operating Margin has declined in the last couple of years.
CLX has a better Gross Margin (44.28%) than 66.67% of its industry peers.
In the last couple of years the Gross Margin of CLX has remained more or less at the same level.
Industry RankSector Rank
OM 15.17%
PM (TTM) 11.68%
GM 44.28%
OM growth 3Y18.52%
OM growth 5Y-2.48%
PM growth 3Y20.6%
PM growth 5Y-3.98%
GM growth 3Y8.04%
GM growth 5Y-0.18%
CLX Yearly Profit, Operating, Gross MarginsCLX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so CLX is creating value.
CLX has less shares outstanding than it did 1 year ago.
The number of shares outstanding for CLX has been reduced compared to 5 years ago.
The debt/assets ratio for CLX is higher compared to a year ago.
CLX Yearly Shares OutstandingCLX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
CLX Yearly Total Debt VS Total AssetsCLX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.2 Solvency

An Altman-Z score of 3.10 indicates that CLX is not in any danger for bankruptcy at the moment.
CLX has a Altman-Z score of 3.10. This is comparable to the rest of the industry: CLX outperforms 50.00% of its industry peers.
CLX has a debt to FCF ratio of 4.25. This is a neutral value as CLX would need 4.25 years to pay back of all of its debts.
The Debt to FCF ratio of CLX (4.25) is worse than 66.67% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 4.25
Altman-Z 3.1
ROIC/WACC2.82
WACC7.78%
CLX Yearly LT Debt VS Equity VS FCFCLX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

2.3 Liquidity

CLX has a Current Ratio of 0.76. This is a bad value and indicates that CLX is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.76, CLX is doing worse than 83.33% of the companies in the same industry.
CLX has a Quick Ratio of 0.76. This is a bad value and indicates that CLX is not financially healthy enough and could expect problems in meeting its short term obligations.
CLX has a worse Quick ratio (0.50) than 91.67% of its industry peers.
Industry RankSector Rank
Current Ratio 0.76
Quick Ratio 0.5
CLX Yearly Current Assets VS Current LiabilitesCLX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

3

3. Growth

3.1 Past

CLX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -10.99%.
Measured over the past 5 years, CLX shows a small growth in Earnings Per Share. The EPS has been growing by 1.01% on average per year.
The Revenue has decreased by -9.35% in the past year.
CLX shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.11% yearly.
EPS 1Y (TTM)-10.99%
EPS 3Y23.44%
EPS 5Y1.01%
EPS Q2Q%-54.3%
Revenue 1Y (TTM)-9.35%
Revenue growth 3Y-0.01%
Revenue growth 5Y1.11%
Sales Q2Q%-18.9%

3.2 Future

Based on estimates for the next years, CLX will show a small growth in Earnings Per Share. The EPS will grow by 1.55% on average per year.
The Revenue is expected to grow by 1.20% on average over the next years.
EPS Next Y-22.5%
EPS Next 2Y-6.04%
EPS Next 3Y-2.23%
EPS Next 5Y1.55%
Revenue Next Year-7.88%
Revenue Next 2Y-1.74%
Revenue Next 3Y-0.22%
Revenue Next 5Y1.2%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
CLX Yearly Revenue VS EstimatesCLX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2B 4B 6B 8B
CLX Yearly EPS VS EstimatesCLX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2 4 6 8

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 15.00 indicates a correct valuation of CLX.
The rest of the industry has a similar Price/Earnings ratio as CLX.
When comparing the Price/Earnings ratio of CLX to the average of the S&P500 Index (26.51), we can say CLX is valued slightly cheaper.
With a Price/Forward Earnings ratio of 14.78, CLX is valued correctly.
CLX's Price/Forward Earnings ratio is in line with the industry average.
The average S&P500 Price/Forward Earnings ratio is at 23.13. CLX is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 15
Fwd PE 14.78
CLX Price Earnings VS Forward Price EarningsCLX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

CLX's Enterprise Value to EBITDA is on the same level as the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CLX is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 19.34
EV/EBITDA 11.71
CLX Per share dataCLX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40

4.3 Compensation for Growth

CLX has a very decent profitability rating, which may justify a higher PE ratio.
A cheap valuation may be justified as CLX's earnings are expected to decrease with -2.23% in the coming years.
PEG (NY)N/A
PEG (5Y)14.81
EPS Next 2Y-6.04%
EPS Next 3Y-2.23%

7

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 5.05%, CLX is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 2.80, CLX pays a better dividend. On top of this CLX pays more dividend than 91.67% of the companies listed in the same industry.
CLX's Dividend Yield is rather good when compared to the S&P500 average which is at 2.00.
Industry RankSector Rank
Dividend Yield 5.05%

5.2 History

The dividend of CLX has a limited annual growth rate of 2.88%.
CLX has been paying a dividend for at least 10 years, so it has a reliable track record.
CLX has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)2.88%
Div Incr Years34
Div Non Decr Years34
CLX Yearly Dividends per shareCLX Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3 4

5.3 Sustainability

CLX pays out 76.11% of its income as dividend. This is not a sustainable payout ratio.
The dividend of CLX is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP76.11%
EPS Next 2Y-6.04%
EPS Next 3Y-2.23%
CLX Yearly Income VS Free CF VS DividendCLX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
CLX Dividend Payout.CLX Dividend Payout, showing the Payout Ratio.CLX Dividend Payout.PayoutRetained Earnings

CLOROX COMPANY

NYSE:CLX (12/31/2025, 7:49:24 PM)

After market: 100.83 0 (0%)

100.83

+0.02 (+0.02%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryHousehold Products
Earnings (Last)11-03 2025-11-03/amc
Earnings (Next)02-02 2026-02-02/amc
Inst Owners89.37%
Inst Owner Change-3.69%
Ins Owners0.4%
Ins Owner Change13.39%
Market Cap12.30B
Revenue(TTM)6.77B
Net Income(TTM)791.00M
Analysts54.81
Price Target125.4 (24.37%)
Short Float %5.81%
Short Ratio3.13
Dividend
Industry RankSector Rank
Dividend Yield 5.05%
Yearly Dividend4.88
Dividend Growth(5Y)2.88%
DP76.11%
Div Incr Years34
Div Non Decr Years34
Ex-Date01-28 2026-01-28 (1.24)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)17.83%
Min EPS beat(2)6.97%
Max EPS beat(2)28.7%
EPS beat(4)3
Avg EPS beat(4)9.13%
Min EPS beat(4)-8.29%
Max EPS beat(4)28.7%
EPS beat(8)7
Avg EPS beat(8)25.3%
EPS beat(12)11
Avg EPS beat(12)52.89%
EPS beat(16)13
Avg EPS beat(16)41.78%
Revenue beat(2)2
Avg Revenue beat(2)1.32%
Min Revenue beat(2)1.06%
Max Revenue beat(2)1.58%
Revenue beat(4)3
Avg Revenue beat(4)0.24%
Min Revenue beat(4)-4.3%
Max Revenue beat(4)2.62%
Revenue beat(8)5
Avg Revenue beat(8)1.13%
Revenue beat(12)9
Avg Revenue beat(12)2.28%
Revenue beat(16)11
Avg Revenue beat(16)1.58%
PT rev (1m)-4.45%
PT rev (3m)-10.61%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-4.56%
EPS NY rev (1m)-0.38%
EPS NY rev (3m)-2.63%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.66%
Revenue NY rev (1m)-0.08%
Revenue NY rev (3m)-0.27%
Valuation
Industry RankSector Rank
PE 15
Fwd PE 14.78
P/S 1.82
P/FCF 19.34
P/OCF 14.42
P/B N/A
P/tB N/A
EV/EBITDA 11.71
EPS(TTM)6.72
EY6.66%
EPS(NY)6.82
Fwd EY6.77%
FCF(TTM)5.21
FCFY5.17%
OCF(TTM)6.99
OCFY6.94%
SpS55.51
BVpS-0.18
TBVpS-14.84
PEG (NY)N/A
PEG (5Y)14.81
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 14.31%
ROE N/A
ROCE 31.18%
ROIC 21.9%
ROICexc 22.99%
ROICexgc 49.37%
OM 15.17%
PM (TTM) 11.68%
GM 44.28%
FCFM 9.39%
ROA(3y)7.31%
ROA(5y)8.13%
ROE(3y)135.14%
ROE(5y)132.26%
ROIC(3y)18.59%
ROIC(5y)17.73%
ROICexc(3y)19.75%
ROICexc(5y)18.87%
ROICexgc(3y)40.28%
ROICexgc(5y)41.99%
ROCE(3y)24.92%
ROCE(5y)23.9%
ROICexgc growth 3Y25.21%
ROICexgc growth 5Y-4.26%
ROICexc growth 3Y28.43%
ROICexc growth 5Y1.01%
OM growth 3Y18.52%
OM growth 5Y-2.48%
PM growth 3Y20.6%
PM growth 5Y-3.98%
GM growth 3Y8.04%
GM growth 5Y-0.18%
F-Score6
Asset Turnover1.22
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 4.25
Debt/EBITDA 2.17
Cap/Depr 98.19%
Cap/Sales 3.2%
Interest Coverage 250
Cash Conversion 68.35%
Profit Quality 80.4%
Current Ratio 0.76
Quick Ratio 0.5
Altman-Z 3.1
F-Score6
WACC7.78%
ROIC/WACC2.82
Cap/Depr(3y)95.76%
Cap/Depr(5y)111.24%
Cap/Sales(3y)3.06%
Cap/Sales(5y)3.44%
Profit Quality(3y)296.87%
Profit Quality(5y)227.9%
High Growth Momentum
Growth
EPS 1Y (TTM)-10.99%
EPS 3Y23.44%
EPS 5Y1.01%
EPS Q2Q%-54.3%
EPS Next Y-22.5%
EPS Next 2Y-6.04%
EPS Next 3Y-2.23%
EPS Next 5Y1.55%
Revenue 1Y (TTM)-9.35%
Revenue growth 3Y-0.01%
Revenue growth 5Y1.11%
Sales Q2Q%-18.9%
Revenue Next Year-7.88%
Revenue Next 2Y-1.74%
Revenue Next 3Y-0.22%
Revenue Next 5Y1.2%
EBIT growth 1Y-13.41%
EBIT growth 3Y18.51%
EBIT growth 5Y-1.39%
EBIT Next Year5.87%
EBIT Next 3Y7.02%
EBIT Next 5Y6.3%
FCF growth 1Y-19.9%
FCF growth 3Y12.46%
FCF growth 5Y-10.05%
OCF growth 1Y-14.7%
OCF growth 3Y7.67%
OCF growth 5Y-8.7%

CLOROX COMPANY / CLX FAQ

Can you provide the ChartMill fundamental rating for CLOROX COMPANY?

ChartMill assigns a fundamental rating of 4 / 10 to CLX.


What is the valuation status for CLX stock?

ChartMill assigns a valuation rating of 4 / 10 to CLOROX COMPANY (CLX). This can be considered as Fairly Valued.


What is the profitability of CLX stock?

CLOROX COMPANY (CLX) has a profitability rating of 6 / 10.


What are the PE and PB ratios of CLOROX COMPANY (CLX) stock?

The Price/Earnings (PE) ratio for CLOROX COMPANY (CLX) is 15 and the Price/Book (PB) ratio is -559.06.


How sustainable is the dividend of CLOROX COMPANY (CLX) stock?

The dividend rating of CLOROX COMPANY (CLX) is 7 / 10 and the dividend payout ratio is 76.11%.